Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11576
CALL
Liberty Global Class C
LBTYK
$3.53B
| $73.4K | ﹤0.01% |
3,600
-31,800
| -90% | -$670K |
|
11577
PUT
Lantronix
LTRX
$283M
| $73.3K | ﹤0.01% |
16,900
+700
| +4% | +$3.28K |
|
11578
Edison International
EIX
$27.3B
| $73.3K | ﹤0.01% |
1,039
+994
| +2,209% | +$67.1K |
|
11579
CALL
SCYNEXIS
SCYX
$52.7M
| $73.2K | ﹤0.01% |
3,050
-1,225
| -29% | -$16.3K |
|
11580
PUT
Superior Group of Companies
SGC
$207M
| $73.2K | ﹤0.01% |
9,300
+2,400
| +35% | +$25.8K |
|
11581
PUT
iShares Micro-Cap ETF
IWC
$1.51B
| $73.2K | ﹤0.01% |
700
+100
| +17% | +$11.2K |
|
|
PRPH
11582
PUT
DELISTED
ProPhase Labs
PRPH
| $73.2K | ﹤0.01% |
960
-310
| -24% | -$25K |
|
|
REVG
11583
CALL
DELISTED
REV Group
REVG
| $73.1K | ﹤0.01% |
6,100
+700
| +13% | +$8.72K |
|
11584
CALL
NextCure
NXTC
$35.2M
| $73.1K | ﹤0.01% |
4,117
-1,000
| -20% | -$19.3K |
|
|
AEY
11585
DELISTED
ADDvantage Technologies Group
AEY
| $73.1K | ﹤0.01% |
6,583
+458
| +7% | +$6.45K |
|
11586
Quad
QUAD
$505M
| $72.9K | ﹤0.01% |
+16,995
| New | +$74.9K |
|
11587
PUT
Invesco CurrencyShares Australian Dollar Trust
FXA
$98.3M
| $72.8K | ﹤0.01% |
1,100
-3,200
| -74% | -$216K |
|
|
GOGL
11588
DELISTED
Golden Ocean Group
GOGL
| $72.8K | ﹤0.01% |
7,648
-11,507
| -60% | -$109K |
|
11589
CALL
Eton Pharmaceutcials
ETON
$1.58B
| $72.8K | ﹤0.01% |
+18,900
| New | +$68.9K |
|
11590
CALL
The Honest Company
HNST
$527M
| $72.7K | ﹤0.01% |
40,400
-4,600
| -10% | -$12.6K |
|
11591
Eledon Pharmaceuticals
ELDN
$278M
| $72.7K | ﹤0.01% |
+30,810
| New | +$82.6K |
|
11592
PUT
NextDecade
NEXT
$1.87B
| $72.6K | ﹤0.01% |
14,600
-17,100
| -54% | -$99.4K |
|
11593
Vor Biopharma
VOR
$1.34B
| $72.5K | ﹤0.01% |
674
-747
| -53% | -$82.8K |
|
11594
CALL
FreightCar America
RAIL
$242M
| $72.4K | ﹤0.01% |
23,200
-6,000
| -21% | -$20.7K |
|
11595
CALL
Torrid Holdings
CURV
$226M
| $72.4K | ﹤0.01% |
16,600
-100
| -0.6% | -$317 |
|
|
NAGE
11596
CALL
Niagen Bioscience
NAGE
$241M
| $72.4K | ﹤0.01% |
47,300
-43,000
| -48% | -$76.6K |
|
|
EEX
11597
DELISTED
Emerald Holding
EEX
| $72.4K | ﹤0.01% |
19,451
-3,650
| -16% | -$13.6K |
|
11598
Broadway Financial
BYFC
$114M
| $72.4K | ﹤0.01% |
+8,614
| New | +$81.1K |
|
11599
CALL
Sasol
SSL
$7.34B
| $72.3K | ﹤0.01% |
5,300
+2,200
| +71% | +$34.2K |
|
11600
CALL
DLH Holdings
DLHC
$67.7M
| $72.3K | ﹤0.01% |
6,300
-2,300
| -27% | -$27.5K |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,467 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.